This antibody recognizes an extracellular epitope of CD267, a 32 kDa type III transmembrane protein expressed by B cells and possibly by some activated T cells.
Applications
Flow Cytometry
Dilutions
Flow Cytometry: The reagent is designed for analysis of human blood cells using 10 µl reagent / 100 µl of whole blood or 106 cells in a suspension. The content of a vial (1 ml) is sufficient for 100 tests.
Reactivity
Human
Immunogen
CD267 transfected RBL cells.
Host
Rat
Clonality
Monoclonal
Clone ID
1A1
Isotype
IgG2a
Light Chains
kappa
Conjugate
APC
Excitation: 645nm, Emission: 660nm
Purification
This antibody is conjugated with Allophycocyanin (APC) under optimum conditions. The conjugate is purified by size-exclusion chromatography; removing unconjugated antibody and free fluorochrome.
Predicted MW
32 kDa
Product Form
Liquid
Formulation
Supplied in Phosphate Buffered Saline, pH 7.4, with 15 mM Sodium Azide.
Storage
Shipped at 4°C. Store in the dark at 2-8°C. Do not freeze!
Synonyms
CD267, TNFRSF13B, Transmembrane activator and CAML interactor, Tumor necrosis factor receptor superfamily member 13B
Separation of human CD267 positive CD19 positive B cells (red-filled) from human CD267 negative CD19 negative lymphocytes (black-dashed) in flow cytometry surface staining of human peripheral whole blood, labeling TACI with Anti-TACI Antibody [1A1] (APC) (A121897), (10 µl reagent / 100 µl of peripheral whole blood).
Publishing research using Anti-TACI Antibody [1A1] (APC) (A121897)? Please let us know so that we can list the citation on this page.
Proteins predicted to interact with TACI
Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.